Max Healthcare Institute Limited
All news and filings related to Max Healthcare Institute Limited.
View all news & filings- High impact
Max Healthcare Q4 Revenue Up 10% YoY to ₹2,664 Cr; PAT Grows 3% to ₹387 Cr
Max Healthcare reported Q4 FY26 revenue of ₹2,664 Cr, up 10% YoY, and PAT of ₹387 Cr, up 3% YoY. The company acquired a controlling stake in Kalinga Hospital Ltd. for an undisclosed amount and approved a ₹1,400 Cr investment for a new greenfield hospital in Lucknow. Capacity expansions are ongoing with phased commissioning of brownfield projects.
Read the summary - Medium impact
Max Healthcare Board Approves FY26 Results, Recommends ₹2 Dividend
Max Healthcare Institute Limited's Board approved FY26 financial results and recommended a final dividend of ₹2 per equity share. The Board also approved the construction of a new hospital in Lucknow and the shifting of its registered office to Haryana. Re-appointment of a director and re-classification of a promoter group entity were also approved.
Read the summary - Medium impact
Max Healthcare Board Approves FY26 Results, Recommends ₹2 Dividend
Max Healthcare's Board approved FY26 audited results and recommended a final dividend of ₹2 per share. The company also approved the construction of a new hospital in Lucknow and the shifting of its registered office to Haryana. Mr. Anil Kumar Bhatnagar was re-appointed as a director.
Read the summary - Medium impact
Max Healthcare faces NCLT petition over Kalinga Hospital subsidiary
Max Healthcare Institute Limited is involved in a litigation at NCLT, Cuttack Bench, filed by BRS Capital Two Pte. Limited concerning alleged oppression and mismanagement at subsidiary Kalinga Hospital Ltd. The NCLT has reserved orders on interim reliefs. The next hearing is scheduled for July 7, 2026.
Read the summary - High impact
Max Healthcare Acquires 58.28% Stake in Kalinga Hospital for ₹297.97 Crore
Max Healthcare acquired ~58.28% stake in Kalinga Hospital Ltd. for ~₹297.97 Crore on May 18, 2026. The acquisition was funded by a Senior Secured Term Loan of up to ₹300 Crore. Kalinga Hospital operates a 250-bed facility in Bhubaneswar, Odisha, and is now a subsidiary of Max Healthcare.
Read the summary - Low impact
Max Healthcare Schedules Q4 & FY26 Earnings Call for May 22
Max Healthcare will hold an earnings call on May 22, 2026, to discuss Q4 & FY26 results declared on May 21, 2026. The senior management will participate in the call.
Read the summary - Low impact
Max Healthcare: Radiant Life Care Foundation seeks re-classification from Promoter Group to Public
Radiant Life Care Hospital Foundation has requested re-classification from Promoter Group to Public category. This follows the sale of equity stake by Mr. Abhay Soi and Radiant Life Care Private Limited. RLCHF currently holds no shares, thus no impact on promoter shareholding is anticipated.
Read the summary - Low impact
Max Healthcare Shareholders Approve Re-appointment of Director Narayan K. Seshadri
Max Healthcare Institute Limited shareholders approved the re-appointment of Mr. Narayan K. Seshadri as Non-Executive and Non-Independent Director via an Ordinary Resolution. The postal ballot process concluded on May 11, 2026, with the resolution deemed passed on that date. The results were reported on May 12, 2026.
Read the summary - Medium impact
Max Healthcare Receives Rectification Order, GST Demand of ₹55.20 Crore Withdrawn
Max Healthcare received a Rectification Order on April 21, 2026, withdrawing the entire GST demand of ₹55.20 crore. This follows an earlier intimation regarding excess Input Tax Credit allegations. The GST authority accepted the company's rectification application.
Read the summary - Low impact
Max Healthcare Publishes Postal Ballot Notice in Newspapers
Max Healthcare Institute Limited published a postal ballot notice on April 12, 2026, for the re-appointment of Director Narayan K. Seshadri. E-voting is open from April 12 to May 11, 2026. Results will be announced by May 13, 2026.
Read the summary - Low impact
Max Healthcare to seek shareholder approval for re-appointment of Director via Postal Ballot
Max Healthcare is seeking shareholder approval for the re-appointment of Mr. Narayan K. Seshadri as Non-Executive and Non-Independent Director for three years from May 16, 2026. E-voting begins April 12, 2026, and ends May 11, 2026. Results will be announced by May 13, 2026.
Read the summary - High impact
Max Healthcare to Acquire Kalinga Hospital for ~₹300 Crore, Re-appoints Director
Max Healthcare will acquire a controlling 58.39% stake in Kalinga Hospital for ~₹300 Crore. The company also approved a ₹100 Crore loan for KHL's upgradation and a $5 Mn corporate guarantee. Mr. Narayan K. Seshadri was re-appointed as Non-Executive Director for three years from May 16, 2026. The acquisition is expected to close within 4-6 weeks.
Read the summary - High impact
Max Healthcare to acquire 58.39% stake in Kalinga Hospital for ₹300 Crore
Max Healthcare will acquire a 58.39% stake in Kalinga Hospital Ltd. for ₹300 Crore. The company will also provide ₹100 Crore in loans for upgrades and secure ₹300 Crore in ECB for financing. Mr. Narayan K. Seshadri was re-appointed as a Non-Executive Director.
Read the summary - High impact
Max Healthcare to acquire 58.39% stake in Kalinga Hospital for ₹300 Crore
Max Healthcare will acquire a 58.39% stake in Kalinga Hospital for ₹300 Crore. It will also provide a ₹100 Crore loan for upgrades. Max Healthcare secured ₹300 Crore in ECB for the acquisition. Mr. Narayan K. Seshadri was re-appointed as a director for three years starting May 16, 2026.
Read the summary - High impact
Max Healthcare to acquire 58.39% stake in Kalinga Hospital for ₹300 Cr
Max Healthcare will acquire a 58.39% stake in Kalinga Hospital Ltd. for ₹300 Crore. The company will also provide a ₹100 Crore loan for upgrades and secure a $5 Million corporate guarantee. Max Healthcare has approved a ₹300 Crore External Commercial Borrowing for the acquisition. Mr. Narayan K. Seshadri's re-appointment as Director was also approved.
Read the summary - Low impact
Max Healthcare: Certificate confirming no share dematerialization requests for Q4 FY26
Max Healthcare Institute Limited received a confirmation certificate for the quarter ended March 31, 2026. The registrar confirmed no share dematerialization requests were processed during this period, as per SEBI regulations. This is a routine compliance filing.
Read the summary - Low impact
Max Healthcare: Trading Window Closed from April 1 for Q4 & FY26 Results
Max Healthcare's trading window will be closed from April 1, 2026. This closure is to facilitate the announcement of financial results for the fourth quarter and full financial year ending March 31, 2026. The window will reopen 48 hours after the results declaration.
Read the summary - Low impact
Max Healthcare subsidiary ET Planners Private Limited stands dissolved by NCLT order
ET Planners Private Limited, a step-down subsidiary of Max Healthcare Institute Limited, has been dissolved by order of the National Company Law Tribunal (NCLT) on March 25, 2026. This dissolution is part of a voluntary liquidation process. Max Healthcare stated that this event will not materially impact its financials or business policies.
Read the summary - Low impact
Max Healthcare to Participate in J.P. Morgan India Forum 2026 in Singapore
Max Healthcare Institute Limited announced its Chairman and Managing Director will participate in the J. P. Morgan India Forum 2026 in Singapore on March 9-10, 2026. The meetings will be physical and include one-on-one and group sessions. No unpublished price-sensitive information will be shared.
Read the summary - Low impact
Max Healthcare Receives Appeal Order on GST Demand, Revises Liability
Max Healthcare received a partial appeal order on a GST demand. The revised liability stands at ₹85.36 lakh for GST, ₹85.36 lakh for penalty, and ₹6.89 lakh for interest. The company is filing a further appeal for the balance demand.
Read the summary - Low impact
Max Healthcare Investor Presentation for 17th Kotak Chasing Growth Conference
Max Healthcare Institute Limited will present at the 17th Kotak Chasing Growth Conference on February 23, 2026. The updated investor presentation details growth strategies, including capacity expansion by ~8,900 beds and focus on digital platforms and capital-light adjacencies. Financials for 9M FY26 show reported EBITDA of ₹1,901 crore and profit after tax of ₹1,244 crore.
Read the summary - Medium impact
Max Healthcare Q3 FY26: Revenue up 10%, EBITDA up 4% amid seasonal softness
Max Healthcare reported Q3 FY26 revenue of ₹2,608 crore, up 10% YoY, and operating EBITDA of ₹648 crore, up 4% YoY. The company commissioned new beds and announced expansion plans, including a 450-bed hospital in Pune by 2030. For 9M FY26, revenue grew 19% to ₹7,874 crore.
Read the summary - Low impact
Max Healthcare to Participate in Nuvama & Kotak Investor Conferences
Max Healthcare Institute Limited will participate in the Nuvama India Conference on February 9, 2026, and the Kotak Chasing Growth Conference on February 23, 2026. An investor presentation will be shared during these events.
Read the summary - Low impact
Max Healthcare Publishes Q3 FY26 Financial Results in Newspapers
Max Healthcare Institute Limited published its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The Board approved the results on February 5, 2026. The disclosures were published in Business Standard and Navshakti on February 6, 2026.
Read the summary - Low impact
Max Healthcare posts Q3 FY26 earnings call audio recording
Max Healthcare Institute Limited has released the audio recording of its earnings call held on February 6, 2026. The call discussed the financial results for the quarter and nine months ended December 31, 2025. The recording is available on the company's website.
Read the summary - High impact
Max Healthcare Q3 Revenue Up 10% YoY to ₹2,608 Cr; PAT Grows 9% to ₹344 Cr
Max Healthcare reported Q3 FY26 revenue of ₹2,608 crore, up 10% YoY. PAT grew 9% YoY to ₹344 crore, after accounting for exceptional items. Network Operating EBITDA was ₹648 crore, up 4% YoY. The company is acquiring Yerawada Properties Pvt. Ltd. for a new 450-bed hospital in Pune, expected by 2030.
Read the summary - High impact
Max Healthcare Q3 FY26 Revenue Up 10% YoY to ₹2,608 Cr; PAT Grows 9% YoY to ₹344 Cr
Max Healthcare Institute Limited reported Q3 FY26 revenue of ₹2,608 crore, up 10% YoY. Network Operating EBITDA grew 4% YoY to ₹648 crore, and PAT increased 9% YoY to ₹344 crore. The company is acquiring Yerawada Properties Pvt. Ltd. for a new Pune hospital, expected by 2030. Brownfield expansions are progressing at multiple sites.
Read the summary - Medium impact
Max Healthcare Approves Q3 FY26 Results and Expands Dwarka Hospital Capacity
Max Healthcare Institute Limited approved Q3 FY26 results on February 5, 2026. The company also approved an expansion of approximately 260 beds at its Dwarka hospital, expected within 24 months. The company will provide a ₹25 crore security deposit. Standalone revenue for nine months was ₹2,14,155 lakh, with PAT ₹51,348 lakh. Consolidated revenue was ₹6,23,056 lakh, with PAT ₹1,10,019 lakh.
Read the summary - Low impact
Max Healthcare to Participate in Two Investor Conferences in February 2026
Max Healthcare Institute Limited will participate in the Nuvama India Conference on February 9, 2026, and the Kotak Chasing Growth Conference on February 23, 2026. Both events will be held physically in Mumbai and will include one-on-one and group meetings. No unpublished price-sensitive information will be shared.
Read the summary - Low impact
Max Healthcare Initiates Voluntary Liquidation of Non-Material Subsidiary MHC Nigeria
Max Healthcare has initiated voluntary liquidation of its non-material subsidiary, MHC Nigeria. The subsidiary's net worth was ₹(70,89,724) as of March 31, 2025, with negligible revenue contribution. This liquidation is not expected to materially impact the company's financials.
Read the summary - Low impact
Max Healthcare Schedules Q3 & 9M FY26 Earnings Call for Feb 6, 2026
Max Healthcare Institute Limited will hold an earnings call on February 6, 2026, at 11:30 AM IST to discuss Q3 & 9M FY26 results. The results will be declared on February 5, 2026. Senior management will be present for the call, which includes a Q&A session.
Read the summary - Low impact
Max Healthcare Receives Certificate for No Dematerialization Requests in Q3 FY26
Max Healthcare Institute Limited received a certificate confirming no share dematerialization requests during the quarter ended December 31, 2025. This complies with SEBI (Depositories and Participants) Regulations, 2018.
Read the summary - Medium impact
Max Healthcare Faces ₹33.66 Crore GST Demand with ₹18.17 Crore Interest
Max Healthcare received an order from GST authorities alleging excess Input Tax Credit. The company faces a GST demand of ₹33.66 crore, ₹18.17 crore in interest, and ₹3.36 crore penalty. Management is seeking rectification and may appeal.
Read the summary - Low impact
Max Healthcare: Trading Window Closed Jan 1, 2026 for Q3 FY26 Results
Max Healthcare's trading window will be closed from January 1, 2026, until 48 hours after the declaration of Q3 FY26 results. The board meeting date to approve these results will be announced later.
Read the summary - Medium impact
Max Healthcare receives GST demand and penalty order of ₹127.32 crore
Max Healthcare received a GST order demanding ₹6,36,56,686 with interest and an equal penalty of ₹6,36,56,686, totaling ₹12,73,13,372. The order concerns alleged discrepancies in Input Tax Credit and tax recovery. The company plans to appeal the order, stating no other financial or operational impact.
Read the summary - High impact
Max Healthcare Invests Over ₹1000 Cr for 450-Bed Hospital in Pune
Max Healthcare is entering Pune with a new 450-bed super speciality hospital, involving an investment exceeding ₹1000 crore. The facility, located in Yerawada, is expected to be commissioned within three years. This marks a strategic expansion into a key healthcare market.
Read the summary - High impact
Max Healthcare to acquire YPPL for ₹200 Cr, plans ₹1,020 Cr hospital in Pune
Max Healthcare will acquire 100% equity in Yerawada Properties Private Limited (YPPL) for ~₹200 Crore. The company plans to set up a ~450-bedded hospital in Pune with an aggregate spend of up to ₹1,020 Crore. The acquisition and hospital development are expected to conclude over ~4 years.
Read the summary - High impact
Max Healthcare to acquire 100% stake in Yerawada Properties for ~₹200 Cr, plans 450-bed hospital in Pune
Max Healthcare will acquire 100% equity in Yerawada Properties Private Limited for ~₹200 Crore. The company plans to set up a ~450-bed super specialty hospital in Pune with an aggregate spend of up to ₹1,020 Crore. The acquisition and hospital setup are expected to be completed over approximately 4 years.
Read the summary - Low impact
Max Healthcare Receives Improved ESG Rating from NSE Sustainability
Max Healthcare's ESG rating improved to '66' for FY25, up from '62' in FY24, as assessed by NSE Sustainability based on public disclosures.
Read the summary - High impact
Max Healthcare Q2 & H1 FY26 Earnings Call Transcript
Max Healthcare's Q2 revenue grew by 21%, EBITDA increased by 23%. Expansion projects are progressing. CGHS revised prices effective October 13th, expecting a favourable impact of over ₹200 crore.
Read the summary - Low impact
Max Healthcare Investor Presentation for Goldman Sachs India CIO Tour
Max Healthcare will participate in the Goldman Sachs 14th India CIO Tour on November 20, 2025, in New Delhi. An updated investor presentation will be used and hosted on the company's website.
Read the summary - Low impact
Max Healthcare Investor Presentation - November 2025
Max Healthcare to participate in investor conferences on November 18 & 20, 2025. Presentation enclosed. The company has a market cap of ₹1.1 lakh crore and is expanding bed capacity.
Read the summary - Low impact
Max Healthcare releases audio recording of earnings call for Q2 FY26 results
Max Healthcare released the audio recording of its earnings call held on November 17, 2025, discussing Q2 FY26 financial results, available on the company website.
Read the summary - High impact
Max Healthcare reports strong Q2FY26 consolidated results; NCLT approves merger, divests hospitals
Max Healthcare announced robust consolidated Q2FY26 results with significant profit growth. NCLT approved the merger of subsidiaries, leading to tax credits. The company also strategically divested two hospitals, focusing on super specialty operations.
Read the summary - High impact
Max Healthcare Q2 FY26 Revenue Soars 21% YoY to ₹2,692 Cr; PAT up 59%
Max Healthcare reported Q2 FY26 revenue of ₹2,692 Cr, up 21% YoY, and PAT of ₹554 Cr, up 59% YoY. Operational EBITDA grew 23%. Company divested two hospitals and commissioned new bed capacities.
Read the summary - High impact
Max Healthcare Reports Strong Q2 FY26 Consolidated Results; Board Approves Merger, Divestment, and Dividend
Max Healthcare reported strong consolidated Q2 FY26 results with significant profit growth. The board approved the merger of subsidiaries and divestment of two hospitals, alongside ESOP grants and dividend payment.
Read the summary - Low impact
Max Healthcare Announces Participation in Investor Conferences
Max Healthcare's Chairman and Senior Management to participate in CLSA 28th India Forum on November 18, 2025, in Mumbai and Goldman Sachs 14th India CIO Tour on November 20, 2025, in New Delhi.
Read the summary - Medium impact
Max Healthcare schedules earnings call for Q2 & H1 FY26 results on November 17, 2025
Max Healthcare will host an earnings call on November 17, 2025, to discuss Q2 & H1 FY26 results, to be declared on November 14, 2025, for investors and analysts.
Read the summary - Medium impact
NCLT sanctions amalgamation of Max Healthcare subsidiaries Crosslay Remedies and Jaypee Healthcare
NCLT approved the amalgamation of Max Healthcare's wholly-owned subsidiaries, Crosslay Remedies and Jaypee Healthcare, effective October 5, 2024, streamlining operations and addressing regulatory concerns.
Read the summary - Low impact
Max Healthcare Receives Improved ESG Score from SES ESG Research
Max Healthcare received an ESG score of 75.1 from SES ESG Research for FY25, improving from 73.7 in FY24. The rating was independently assigned based on public disclosures.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio